skip to main content

Study Overview

A collaboration between the National Institutes of Health (NIH) and the Food and Drug Administration (FDA), the study was launched in 2011 and started the first wave of data collection in 2013.

The PATH Study was one of the first tobacco projects that NIH and FDA have worked on together since Congress gave FDA authority to regulate tobacco products. The study looks at tobacco use and how it affects the health of people in the U.S.

Here is the latest PATH Study newsletter.

Research Objectives

The PATH Study is looking at:

Reasons why some people use tobacco and others do not.

How and why people:

  • Start using tobacco,
  • Start using different types of tobacco products,
  • Use two or more tobacco products, and
  • Switch from one tobacco product to another.

How people quit using tobacco.

Reasons why some people who quit using tobacco start using it again.

Changes in people’s attitudes toward tobacco over time.

Differences in tobacco-use related attitudes, behaviors, and health among:

  • Men and women,
  • People of different races and ethnic groups, and
  • People of different ages.

Impact

Information from the PATH Study is helping NIH and FDA to understand tobacco use behaviors and how use affects health over time. Findings from the study inform FDA’s regulatory decisions and actions under the 2009 Family Smoking Prevention and Tobacco Control ACT.

Study Team

Leading the Study

Scientists at the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) are leading the PATH Study.

They are working with Westat, a research company in Maryland that has expertise in survey design, questionnaire development, data collection, and analysis. Westat manages a team of partner organizations in conducting a variety of health studies.

Partner Organizations

Partner organizations involved in the PATH Study have expertise in tobacco research, including tobacco use behaviors, health conditions, and research methods. They also lead focused research studies to address the PATH Study’s objectives. The Principal Investigator of the PATH Study, Dr. Andrew Hyland, is located at one of the partner organizations, Roswell Park Comprehensive Cancer Center. Other scientists participating in the PATH Study are also from Roswell Park Comprehensive Cancer Center, as well as from these organizations:

Our Field Interviewers

The PATH Study interviewers love their work. One of the best parts of their job is meeting and talking with you, our participants. Roll over the areas of the country and see what the interviewers have to say!

You can recognize our Field Interviewers by their distinctive PATH Study badge. Did you know that if you are contacted by someone who says they work on the PATH Study you can verify their identity? It is easy, just click on the “Verify My Field Interviewer” button below and we will check for you.

sample PATH badge
back to top